- Q1 2024 Vir Biotechnology Inc Earnings Call TranscriptMay 02, 2024$9.18 (+5.03%)Earnings
- Q4 2023 Vir Biotechnology Inc Earnings Call TranscriptFeb 22, 2024$10.3 (+1.88%)Earnings
- Vir Biotechnology Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Vir Biotechnology Inc AASLD Late Breaking Data Update Call TranscriptNov 13, 2023
- Q3 2023 Vir Biotechnology Inc Earnings Call TranscriptNov 02, 2023$8.19 (+5.13%)Earnings
- Vir Biotechnology Inc at H.C. Wainwright & Co LLC 4th Annual Hepatitis B Virus (HBV) Conference (Virtual) TranscriptOct 25, 2023
- Vir Biotechnology Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Q2 2023 Vir Biotechnology Inc Earnings Call TranscriptAug 03, 2023$13.97 (-0.50%)Earnings
- Vir Biotechnology Inc at Goldman Sachs Healthcare Conference TranscriptJun 12, 2023
- Vir Biotechnology Inc at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Vir Biotechnology Inc at Needham Healthcare Conference (Virtual) TranscriptApr 18, 2023
- Vir Biotechnology Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2023
- Vir Biotechnology, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-10-2023 09:45 AM TranscriptJan 10, 2023
- Vir Biotechnology Inc at H C Wainwright NASH Investor Conference (Virtual) TranscriptOct 18, 2022
- Vir Biotechnology Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2022
- Vir Biotechnology Inc at Needham Healthcare Conference (Virtual) TranscriptApr 11, 2022
- Vir Biotechnology Inc Corporate Call on Sotrovimab's Retained Activity Against the Omicron SARS-CoV-2 Variant TranscriptDec 07, 2021
- Vir Biotechnology Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
Vir Biotechnology Inc at Needham Healthcare Conference (Virtual) Transcript
Good morning, everyone. Thank you for joining the 21st Annual Needham Healthcare Conference. My name is Joey Stringer; I'm one of the biotech analysts at Needham & Company. It's my pleasure to introduce our next presenting company, Vir Biotechnology. And joining us today from Vir is CMO, Phil Pang. (Conference Instructions)
And with that, we'll get started. I'll turn it over to Phil for some brief opening remarks, and then we'll go ahead and get started with the chat.
Joey, thank you so much. And as always, I want to begin by a disclaimer that I will be making some forward-looking statements and that for additional details, you should see our SEC filings.
So, Joey, just to begin, this is really an extraordinary and pivotal time for Vir, and I really want to emphasize that. In just five years since we were founded, we've brought a transformative life-saving medication to patients called sotrovimab, which is our COVID
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)